STAAR Surgical Co., based in Monrovia, California, designs and manufactures ophthalmic surgical products, employing 1,056 staff and selling lenses globally in approximately 75 countries. Their EVO family of lenses treats myopia and hyperopia, providing visual freedom.
Staar Surgical Company (STAA) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Staar Surgical Company's actual EPS was -$0.50, missing the estimate of $0.02 per share, resulting in a -103.04% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
